Related references
Note: Only part of the references are listed.Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas
Tove Olafsen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors
Jeffrey V. Leyton et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Site-Specific, Thiol-Mediated Conjugation of Fluorescent Probes to Cysteine-Modified Diabodies Targeting CD20 or HER2
Shannon J. Sirk et al.
BIOCONJUGATE CHEMISTRY (2008)
Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct
Marcus P. Kelly et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment
Tove Olafsen et al.
NATURE PROTOCOLS (2006)
Quantitative immuno-positron emission tomography imaging oil HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody
MK Robinson et al.
CANCER RESEARCH (2005)
Arming antibodies: prospects and challenges for immunoconjugates
AM Wu et al.
NATURE BIOTECHNOLOGY (2005)
Characterization of engineered anti-pI85HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting
T Olafsen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers
MAE Arndt et al.
FEBS LETTERS (2004)
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications
T Olafsen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. site-specific conjugation of DOTA-peptides to a cys-diabody
L Li et al.
BIOCONJUGATE CHEMISTRY (2002)
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments
PJ Yazaki et al.
BIOCONJUGATE CHEMISTRY (2001)
ScFv multimers of the anti-neuraminidase antibody NC10:: shortening of the linker in single-chain Fv fragment assembled in VL to VH orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers
O Dolezal et al.
PROTEIN ENGINEERING (2000)
Share Paper
